Keyphrases
Helicobacter Pylori (H. pylori)
100%
Colorectal Cancer
87%
Colonoscopy
78%
Cancer Prevention
58%
Inflammatory Bowel Disease
54%
Familial Adenomatous Polyposis
53%
Polyps
49%
Israeli
46%
Helicobacter Pylori Infection
45%
Israel
44%
Colon
43%
Intestinal Tumor
43%
Adenoma
43%
Small Intestine
41%
Early Detection
39%
Triple Therapy
38%
Polyposis Syndromes
38%
Ulcerative Colitis
37%
Colorectal Neoplasms
34%
Tumor
34%
Crohn's Disease
34%
Methotrexate
31%
CD24
31%
Gastroesophageal Reflux Disease
31%
Odds Ratio
31%
Colorectal Cancer Screening
30%
Remission
30%
Polymorphism
29%
Israeli Population
28%
Placebo
27%
Cancer Risk
26%
Duodenal Ulcer
25%
Screening Colonoscopy
25%
Histology
24%
Adenoma Detection Rate
24%
Metronidazole
23%
Dyspepsia
23%
Peptic Ulcer Disease
22%
Neoplasia
22%
Confidence Interval
21%
Colorectal Adenoma
21%
Advanced Adenoma
21%
Adhesiveness
20%
Leukocytes
20%
Abdominal Pain
20%
Omeprazole
20%
Diagnosis Treatment
20%
Multicenter Trial
20%
Interferon Treatment
20%
Serum Iron
20%
Medicine and Dentistry
Colonoscopy
87%
Colorectal Carcinoma
80%
Adenoma
76%
Helicobacter Pylori
62%
Neoplasm
59%
Polyp
58%
Malignant Neoplasm
46%
Diseases
44%
Intestine Tumor
43%
Polyposis
39%
Cancer Prevention
38%
Cancer
37%
Endoscopy
35%
Ulcerative Colitis
33%
Familial Adenomatous Polyposis
32%
Prevalence
31%
Patient with Inflammatory Bowel Disease
31%
Colorectal Tumor
31%
Colon
28%
Primary Health Care
24%
Combination Therapy
23%
Stomach Acid
23%
Crohn's Disease
22%
Omeprazole
22%
Dysplasia
22%
Leukocyte
21%
Health Care Cost
21%
Leukocyte Adherence
20%
Gastroesophageal Reflux
20%
Cancer Screening
20%
Tubular Adenoma
20%
Colorectal Cancer Screening
20%
Capsule Endoscopy
19%
Abdominal Pain
18%
Duodenum Ulcer
17%
Colorectal Adenoma
17%
Cyclooxygenase 2 Inhibitor
17%
Placebo
17%
Adenocarcinoma
16%
Clinical Trial
16%
Controlled Clinical Trial
15%
Carcinogenesis
14%
Barrett Esophagus
14%
Clarithromycin
14%
Tinidazole
14%
Colon Carcinoma
14%
APC
13%
Polypectomy
13%
Cancer Risk
12%
Colorectal Cancer Prevention
12%
Pharmacology, Toxicology and Pharmaceutical Science
Helicobacter Pylori
68%
Colorectal Carcinoma
58%
Polyp
46%
Remission
43%
Malignant Neoplasm
38%
Ulcerative Colitis
35%
Helicobacter Infection
32%
Diseases
32%
Methotrexate
31%
Adenoma
28%
Crohn's Disease
26%
Placebo
26%
Inflammatory Bowel Disease
23%
Neoplasm
23%
COX-2 Inhibitor
22%
Colorectal Tumor
21%
Infection
21%
Recurrent Disease
19%
Colon Carcinoma
18%
Metronidazole
17%
Duodenum Ulcer
17%
Carcinogenesis
17%
Familial Adenomatous Polyposis
15%
Prevalence
15%
Antibiotics
13%
Diarrhea
13%
Urea Breath Test
13%
Inflammation
12%
Omeprazole
12%
Chronic Hepatitis C
12%
Antiinfective Agent
12%
Jejunum Ulcer
12%
Tinidazole
12%
Cytotoxin
12%
Peptic Ulcer
12%
Aminosalicylic Acid
11%
Combination Therapy
11%
Clinical Study
11%
Adenomatous Polyp
11%
Oxazepam
10%
Phospholipid
10%
Colon Polyposis
10%
Streptococcus equinus
10%
Glaucoma
10%
Syndrome
10%
Pseudomembranous Colitis
10%
Acetylsalicylic Acid
10%
Transferrin
10%
Iron
10%
Blister
10%